Clik here to view.
Targeting a key driver of cancer
Originally posted on lyranara.me: In a recent breakthrough, a team led by UCSF’s Kevan Shokat was able to exploit a previously unknown “Achilles heel” in K-Ras, part of a family of protein mutations...
View ArticleClik here to view.
WHITE PAPER: QA/QC: Catching Up With The Competiton
WHITE PAPER: QA/QC: Catching Up With The Competiton By Robert G. McGregor, General Manager, Brookfield Engineering Laboratories, Inc. In the world of pharmaceutical products, there is almost always a...
View ArticleClik here to view.
DARA BioSciences receives FDA orphan drug designation for KRN5500 (SPK 241)...
KRN5500 Antitumor agent 151276-95-8 cas IUPAC/Chemical name:...
View ArticleClik here to view.
The five largest Intellectual Property (IP) offices in the world discussed...
Worldwide Intellectual Property Service The five largest Intellectual Property (IP) offices in the world discussed how to further increase co-operation Read more...
View ArticleClik here to view.
Computer-designed protein triggers self-destruction of Epstein-Barr-infected...
Originally posted on lyranara.me: A small chunk of protein (red) bound to the Epstein-Barr virus target protein (gray) was extended to make a much longer protein, left, and then designed to have a...
View ArticleClik here to view.
Do salamanders hold the key to limb regeneration?
Originally posted on lyranara.me: This is an image of a salamander (the newt Notophthalmus viridescens). Credit: University College London The secret of how salamanders successfully regrow body parts...
View ArticleClik here to view.
Developing an improved liposuction technique that melts fat
Originally posted on lyranara.me: Although liposuction is one of the most common and well-established cosmetic surgery procedures in the U.S., it still has its drawbacks. But a new biomedical start-up...
View ArticleClik here to view.
A better imager for identifying tumors
Originally posted on lyranara.me: This is (a) Optical and mechanical structure of the customized lens with aperture filter and (b) the photograph of the assembled lens, with a quarter for comparison....
View ArticleClik here to view.
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?
Originally posted on Pharmaceutical Intelligence: Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View? Author: Larry H. Bernstein, MD, FCAP A Critical Review What is the...
View ArticleClik here to view.
Ebola outbreak in West Africa ‘out of control’
Originally posted on Atasteofcreole's Blog: http://www.foxnews.com/health/2014/06/20/ebola-outbreak-in-west-africa-out-control/?intcmp=latestnews A senior official for Doctors Without Borders says the...
View ArticleClik here to view.
Quantum biology: Algae evolved to switch quantum coherence on and off
Originally posted on lyranara.me: A scanning electron microscope image of cryptophytes. A UNSW Australia-led team has discovered how cryptophytes that survive in very low levels of light are able to...
View ArticleClik here to view.
An off-switch for drugs’ toxic side effects
Originally posted on lyranara.me: When medications linger in the human body, they sometimes produce toxic side effects. Professor Alexandros Makriyannis, the George D. Behrakis Trustee Chair in...
View ArticleClik here to view.
Molecular biology mystery unravelled
Originally posted on lyranara.me: The nature of the machinery responsible for the entry of proteins into cell membranes has been unravelled by scientists, who hope the breakthrough could ultimately be...
View ArticleClik here to view.
Hetero launches darbepoetin alfa biosimilar in India
The Hetero Group, one of the largest manufacturers and suppliers of activepharmaceutical ingredients to the Indian pharmaceutical industry, yesterdayannounced the launch of its first biosimilar...
View ArticleClik here to view.
FDA approves Cubist’s Sivextro Tedizolid to treat skin infections
June 21, 2014 Regulators in the USA have given the green light to Cubist Pharmaceuticals’ antibiotic Sivextro for serious skin infections, including those caused by MRSA. The US Food and Drug...
View ArticleClik here to view.
Sanofi gives back rights to Merrimack cancer drug
After a series of late-stage failures, Sanofi has returned the rights to the cancer compound MM-121 to Merrimack Pharmaceuticals. MM-121, a monoclonal antibody designed to block ErbB3 activation in...
View ArticleClik here to view.
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer...
Angiogenesis is a valid target in the treatment of epithelial ovarian cancer. Trebananib inhibits the binding of angiopoietins 1 and 2 to the Tie2 receptor, and thereby inhibits angiogenesis. We aimed...
View ArticleClik here to view.
Takeda Pharmaceutical
Takeda Pharmaceutical by Dr. Rainer Steinbach Rainer studied chemistry and economics in Germany (Bonn, Marburg) and did postdoctoral work at Stanford University (CA, USA). He held various positions...
View ArticleClik here to view.
AZD 6564 in preclinical for Antifibrinolytics
AZD 6564 ACS Med. Chem. Lett., 2014, 5 (5), pp 538–543 DOI: 10.1021/ml400526d SYNTHESIS SUPP INFO…..http://pubs.acs.org/doi/suppl/10.1021/ml400526d/suppl_file/ml400526d_si_001.pdf NMR PG 16/32 AS...
View ArticleClik here to view.
Biocon chief Kiran Mazumdar-Shaw receives Kiel Institute’s ’2014 Global...
The award, established in 2005 by the Kiel Institute, is bestowed upon individuals who have been pioneers in finding solutions to global economic problems. BANGALORE: Biotech major Biocon today said...
View Article